Presentation on Hospital Training
at
250 Bedded General Hospital, Pabna
Submitted By
ID NO. : 161328
REG. NO. : 1135110
SESSION : 2015-2016
Department of Pharmacy
Pabna University of Science and Technology.
2
CONTENTS
❑Introduction.
❑Hospital Overview.
❑Prescription Analysis.
❑SWOT Analysis.
❑Conclusion.
❑References.
CHAPTER 01:
INTRODUCTION
Content
❑Hospital Pharmacy.
❑Roles of A Hospital Pharmacist.
❑Objectives of the Training.
A hospital is a health care institution providing patient treatment with specialized medical,
nursing staff and medical equipment.
❑ Proper medical care.
❑ Patient Support.
❑ Preventive and promotive health care.
❑ Rehabilitation services (physiotherapy, occupational therapy etc.)
❑ Healthcare professionals.
❑ Clinical research.(1)
4
Hospital
Hospital Pharmacy is one of the key departments in hospitals that deals with
procurement, storage, compounding, dispensing, manufacturing, testing.
5
❖Form of medication best suits each patient.
❖Monitoring the effects of the medications.
❖Monitoring the outcomes of treatments.
❖Supporting other Healthcare professionals.
❖Route of administration.
❖Monitoring supply of medicines.
(2)
Roles of a Hospital Pharmacist
Objectives of the Training
➢ Hospital activities.
➢ Real life scenario.
➢ Interaction with other Healthcare Professionals.
➢ Prescription pattern.
➢ Polypharmacy.
➢ Drug induced harmful reactions.
➢ Prescription Errors.
➢ Critical condition management.
6
CHAPTER 02:
OVERVIEW of HOSPITAL
Content
❑Brief Introduction.
❑Departments.
❑Common Medications.
OVERVIEW OF HOSPITAL
Name: 250 Bedded General Hospital, Pabna.
Year Established: 1919
Ownership: Fully Government.
Health Care Level: Secondary.
Location: Shalgarhia, Pabna.
Manpower: Assistant Director: 01
Senior Consultant: 10
Junior Consultant: 10
Nurse: 180 Total: 384
8
Departments
Surgery
Department
Medicine
Department
Obstetrics and
Gynecology
Pharmacy
▪ Orthopedic Ward
▪ Male Ward
▪ Female Ward
• Male Ward
• Female Ward
• CCU Unit
• Diarrhea Ward
▪ Pediatric Ward
9
10
Common classes of drug
Anesthetic
E.g. Lidocaine
Tranquilizers
E.g. Benzodiazepines
Miscellaneous
E.g. Salbutamol
Antibiotics
E.g. Ceftriaxone, flucloxacillin,
penicillin.
Antiprotozoal
E.g. Metronidazole
Antihypertensives
E.g. Amlodipine
Proton pump inhibitor
E.g. Esomeprazole
Anti-emetic
E.g. Domperidon, Ondansetron.
Analgesics and antipyretics
E.g. Paracetamol, Tramadol
Hydrochloride, Ketorolac.
CHAPTER 03:
Prescription Analysis
Content
01. Medicine.
02.Surgery & Orthopedics.
03.Labor and Gynecology.
04.Pediatrics.
12 Name : Shanta
Age : 20 years
Sex : Female
Address :Gopalpur, Pabna
Date of admission : 21.05.22
O/E
 BP: 100/80 mm/Hg
 Pulse: 70 beats/min.
 Anemia: Absent
C/C
 SOB.
 Chest Pain.
Diagnosis
❖ Hb%: 9.9 g/dl
❖ Blood grouping & Rh typing
Management
Patient Profile
Management
21.05.2022
➢ Diet: Normal
➢ Inf N/S 1L, Iv stat 25 d/min
➢ Tab Deleta (1+1+0)
➢ Tab Propanolol 10 (1+1+1)
➢ Cap. Dexilend (1+1+0)
➢ Tab Rivo 0.5 (0+0+1)
P/A
➢ Tab. Cefixim 400 (1+0+1)
P/A 31.05.22
• Inj. Algin 1 amp I/M stat
P/A 01.06.22
• Tab Algin (1+1+1)
Medicine ward
Recommendation
❑ As the patient was prescribed cefixime there might be a chance of allergic conditions
happening or improper bowel movement. So, this had to be considered by the physician.
❑ Deleta is problematic for people undergoing therapy with MAOIs, which may cause intense
CNS depression.
❑ Algin is problematic to patients with glaucoma.
❑ Cefixime will not work for viral infections (such as common cold, flu). Using any antibiotic
when it is not needed can cause it to not work for future infections.(3)
13
Attachment
14
15
➢ Diet-NPO TFO
➢ Inj. Flucloxacillin 500 mg-1vial I/V stat & 6
hourly.
➢ Inj. Ketorolac 30 mg- 1 amp I/M stat &
TDS
➢ Inj. Esomeprazole 40 mg- 1vial
I/V stat & BD
➢ Inj. Ceftriaxone 1g- 1vial I/V stat
& BD
➢ Inj. Emistat 8mg 1amp iv stat &
BD
➢ Tab. p/c 500mg (1+1+1)
➢ Inj. N/S (1L) +5% DNS
(1L) I/V stat 20d/min
Name: Asad
Age: 45 years
Sex: Male
Address: Ataykula,
Pabna
Admission date:
23.05.2022
C/C
Cell injury to mouth
Hx
RTA
Diagnosis
CT scan of head
CBC
Patient Profile Management
Surgery ward
16 Recommendation
❑ Flucloxacillin, Ceftriaxone should be given with caution to patients with a history of
hypersensitivity reactions.
❑ As antibiotics are very powerful and destroy normal flora, this combination of two
antibiotics may cause intolerable abdominal distress.
❑ Ketorolac should not be used for longer than 5 days, it may cause serious side effects,
especially when taken improperly.
17
Attachment
18
o Name: Julekha
o Age: 26 years
o Sex: female
o Address: Kumarpur, Pabna
C/C
• Amenorrhea for 29 wks
• Abdominal pain
• Fever for 2 days
H/O
• Para: 1 NVD+ 1 Abortion
• Gravida: 3rd
• E.D.D: 29.07.2022
O/E
▪ BP: 120/80 mmHg.
▪ Absence of anemia.
Management
21.05.2022
• Diet: Normal
• Cap. Esomeprazole 20
• (1+0+1)
• Tab. P/C 500 mg
(1+0 +1)
• Tab. Hysomide 20
(1+1+1)
Patient Profile Management
Labor ward
19 Recommendation
❑ Hysomide is problematic for patients with benign prostatic hyperplasia, urinary
retention, closed-angle glaucoma, tachycardia.
❑ Hysomide also seems to lower CNS activity which may lead to respiratory depression
and ultimately lead to coma.
❑ Should avoid other medications that also have anti-cholinergic effects./
❑ It is permissible in pregnancy only if the potential benefits outweigh the potential
risks.(3)
20
Attachment
Name: Kawsar
Age: 5 years
Sex: Male
Address: Ataikula, Pabna.
C/C
Poisoning (diesel oil).
Vomiting.
H/O
Para: 1 NVD+ 1 Abortion
Gravida: 3rd L.M.P?
E.D.D: 08.09.2022
O/E
BP: 100/60 mmHg
Weight: 20 kg
Diagnosis
Chest X-ray.
➢ Diet NPO. TFO
➢ Inf. APN 500ml+ 5% DA
500 ml - I/V stat @ 8
drops/min
➢ Inj. Ceftriaxone 1 gm – 1
vial I/V stat, bd
➢ Inj. Esotid 40 mg (I/V stat
12 hourly)
➢ Inj. Lasix 1 amp. I/V stat
P/A.
➢Syp. Napa-
1 TFS TDS
21
Patient Profile Management
Pediatric ward
22 Recommendation
❑ As the patient is of very little age, ceftriaxone’s hypersensitivity reactions may cause
severe fatal conditions which may be intolerable for the child.
❑ Ceftriaxone is problematic for patients with gallbladder disease, kidney disease, liver
disease, intestinal disease. So, physician should always check for this before prescribing.
❑ Forced diuresis may cause the patient severe dehydration so, dextrose solution should be
continually administered.(3)
23
Attachment
CHAPTER 04:
SWOT Analysis
Content
❑ Strength
❑ Weakness
❑ Opportunities
❑ Threats
SWOT
SWOT Analysis Findings
Strengths Affordable, Highly accessible, Internship Program, Experienced
physicians ,Reputation, Trained staffs.
Weaknesses Unhygienic environment, Old and inefficient building structure, Lack of
technological advancements, Low doctor to patient ratio, Inefficient
Patient monitoring.
Opportunities Improved medical procedures, Research and innovation, therapeutic
data monitoring, Digitalized records, Infrastructure facilities.
Threats Budget constraints, Salary issue , Hospital acquired infection (HAI),
Patient satisfaction , Rising cost.
CHAPTER 05:
Conclusion
CONCLUSION
Pabna General Hospital is a public hospital ,funded by govt. It’s obvious
that we won’t get quality treatment compared to high-end private
hospital. There is no A grade pharmacist working in the hospital, low
technology usage , inadequate physician and staff, lack of patient
monitoring, inefficient patient medication history checking. However, it
is a heaven for poor people, they can come here and get well with a low
cost. There are a lots of area where improvements can be done. People
involved are trying hard to improve the total service with best effort &
team spirit. 27
References
1. Vedantu. Hospital [Internet]. VEDANTU. Vedantu; 2022 [cited
2022Nov12]. Available from: https://www.vedantu.com/biology/hospital
2. Hospital pharmacist [Internet]. Hospital Pharmacist - an overview |
ScienceDirect Topics. [cited 2022Nov12]. Available from:
https://www.sciencedirect.com/topics/nursing-and-health-
professions/hospital-pharmacist
3. Ketorolac: Medlineplus Drug Information [Internet]. MedlinePlus. U.S.
National Library of Medicine; [cited 2022Nov12]. Available from:
https://medlineplus.gov/druginfo/meds/a693001.html
28
29

Hospital Training Presentation.pdf

  • 1.
    Presentation on HospitalTraining at 250 Bedded General Hospital, Pabna Submitted By ID NO. : 161328 REG. NO. : 1135110 SESSION : 2015-2016 Department of Pharmacy Pabna University of Science and Technology.
  • 2.
  • 3.
    CHAPTER 01: INTRODUCTION Content ❑Hospital Pharmacy. ❑Rolesof A Hospital Pharmacist. ❑Objectives of the Training.
  • 4.
    A hospital isa health care institution providing patient treatment with specialized medical, nursing staff and medical equipment. ❑ Proper medical care. ❑ Patient Support. ❑ Preventive and promotive health care. ❑ Rehabilitation services (physiotherapy, occupational therapy etc.) ❑ Healthcare professionals. ❑ Clinical research.(1) 4 Hospital
  • 5.
    Hospital Pharmacy isone of the key departments in hospitals that deals with procurement, storage, compounding, dispensing, manufacturing, testing. 5 ❖Form of medication best suits each patient. ❖Monitoring the effects of the medications. ❖Monitoring the outcomes of treatments. ❖Supporting other Healthcare professionals. ❖Route of administration. ❖Monitoring supply of medicines. (2) Roles of a Hospital Pharmacist
  • 6.
    Objectives of theTraining ➢ Hospital activities. ➢ Real life scenario. ➢ Interaction with other Healthcare Professionals. ➢ Prescription pattern. ➢ Polypharmacy. ➢ Drug induced harmful reactions. ➢ Prescription Errors. ➢ Critical condition management. 6
  • 7.
    CHAPTER 02: OVERVIEW ofHOSPITAL Content ❑Brief Introduction. ❑Departments. ❑Common Medications.
  • 8.
    OVERVIEW OF HOSPITAL Name:250 Bedded General Hospital, Pabna. Year Established: 1919 Ownership: Fully Government. Health Care Level: Secondary. Location: Shalgarhia, Pabna. Manpower: Assistant Director: 01 Senior Consultant: 10 Junior Consultant: 10 Nurse: 180 Total: 384 8
  • 9.
    Departments Surgery Department Medicine Department Obstetrics and Gynecology Pharmacy ▪ OrthopedicWard ▪ Male Ward ▪ Female Ward • Male Ward • Female Ward • CCU Unit • Diarrhea Ward ▪ Pediatric Ward 9
  • 10.
    10 Common classes ofdrug Anesthetic E.g. Lidocaine Tranquilizers E.g. Benzodiazepines Miscellaneous E.g. Salbutamol Antibiotics E.g. Ceftriaxone, flucloxacillin, penicillin. Antiprotozoal E.g. Metronidazole Antihypertensives E.g. Amlodipine Proton pump inhibitor E.g. Esomeprazole Anti-emetic E.g. Domperidon, Ondansetron. Analgesics and antipyretics E.g. Paracetamol, Tramadol Hydrochloride, Ketorolac.
  • 11.
    CHAPTER 03: Prescription Analysis Content 01.Medicine. 02.Surgery & Orthopedics. 03.Labor and Gynecology. 04.Pediatrics.
  • 12.
    12 Name :Shanta Age : 20 years Sex : Female Address :Gopalpur, Pabna Date of admission : 21.05.22 O/E  BP: 100/80 mm/Hg  Pulse: 70 beats/min.  Anemia: Absent C/C  SOB.  Chest Pain. Diagnosis ❖ Hb%: 9.9 g/dl ❖ Blood grouping & Rh typing Management Patient Profile Management 21.05.2022 ➢ Diet: Normal ➢ Inf N/S 1L, Iv stat 25 d/min ➢ Tab Deleta (1+1+0) ➢ Tab Propanolol 10 (1+1+1) ➢ Cap. Dexilend (1+1+0) ➢ Tab Rivo 0.5 (0+0+1) P/A ➢ Tab. Cefixim 400 (1+0+1) P/A 31.05.22 • Inj. Algin 1 amp I/M stat P/A 01.06.22 • Tab Algin (1+1+1) Medicine ward
  • 13.
    Recommendation ❑ As thepatient was prescribed cefixime there might be a chance of allergic conditions happening or improper bowel movement. So, this had to be considered by the physician. ❑ Deleta is problematic for people undergoing therapy with MAOIs, which may cause intense CNS depression. ❑ Algin is problematic to patients with glaucoma. ❑ Cefixime will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.(3) 13
  • 14.
  • 15.
    15 ➢ Diet-NPO TFO ➢Inj. Flucloxacillin 500 mg-1vial I/V stat & 6 hourly. ➢ Inj. Ketorolac 30 mg- 1 amp I/M stat & TDS ➢ Inj. Esomeprazole 40 mg- 1vial I/V stat & BD ➢ Inj. Ceftriaxone 1g- 1vial I/V stat & BD ➢ Inj. Emistat 8mg 1amp iv stat & BD ➢ Tab. p/c 500mg (1+1+1) ➢ Inj. N/S (1L) +5% DNS (1L) I/V stat 20d/min Name: Asad Age: 45 years Sex: Male Address: Ataykula, Pabna Admission date: 23.05.2022 C/C Cell injury to mouth Hx RTA Diagnosis CT scan of head CBC Patient Profile Management Surgery ward
  • 16.
    16 Recommendation ❑ Flucloxacillin,Ceftriaxone should be given with caution to patients with a history of hypersensitivity reactions. ❑ As antibiotics are very powerful and destroy normal flora, this combination of two antibiotics may cause intolerable abdominal distress. ❑ Ketorolac should not be used for longer than 5 days, it may cause serious side effects, especially when taken improperly.
  • 17.
  • 18.
    18 o Name: Julekha oAge: 26 years o Sex: female o Address: Kumarpur, Pabna C/C • Amenorrhea for 29 wks • Abdominal pain • Fever for 2 days H/O • Para: 1 NVD+ 1 Abortion • Gravida: 3rd • E.D.D: 29.07.2022 O/E ▪ BP: 120/80 mmHg. ▪ Absence of anemia. Management 21.05.2022 • Diet: Normal • Cap. Esomeprazole 20 • (1+0+1) • Tab. P/C 500 mg (1+0 +1) • Tab. Hysomide 20 (1+1+1) Patient Profile Management Labor ward
  • 19.
    19 Recommendation ❑ Hysomideis problematic for patients with benign prostatic hyperplasia, urinary retention, closed-angle glaucoma, tachycardia. ❑ Hysomide also seems to lower CNS activity which may lead to respiratory depression and ultimately lead to coma. ❑ Should avoid other medications that also have anti-cholinergic effects./ ❑ It is permissible in pregnancy only if the potential benefits outweigh the potential risks.(3)
  • 20.
  • 21.
    Name: Kawsar Age: 5years Sex: Male Address: Ataikula, Pabna. C/C Poisoning (diesel oil). Vomiting. H/O Para: 1 NVD+ 1 Abortion Gravida: 3rd L.M.P? E.D.D: 08.09.2022 O/E BP: 100/60 mmHg Weight: 20 kg Diagnosis Chest X-ray. ➢ Diet NPO. TFO ➢ Inf. APN 500ml+ 5% DA 500 ml - I/V stat @ 8 drops/min ➢ Inj. Ceftriaxone 1 gm – 1 vial I/V stat, bd ➢ Inj. Esotid 40 mg (I/V stat 12 hourly) ➢ Inj. Lasix 1 amp. I/V stat P/A. ➢Syp. Napa- 1 TFS TDS 21 Patient Profile Management Pediatric ward
  • 22.
    22 Recommendation ❑ Asthe patient is of very little age, ceftriaxone’s hypersensitivity reactions may cause severe fatal conditions which may be intolerable for the child. ❑ Ceftriaxone is problematic for patients with gallbladder disease, kidney disease, liver disease, intestinal disease. So, physician should always check for this before prescribing. ❑ Forced diuresis may cause the patient severe dehydration so, dextrose solution should be continually administered.(3)
  • 23.
  • 24.
    CHAPTER 04: SWOT Analysis Content ❑Strength ❑ Weakness ❑ Opportunities ❑ Threats
  • 25.
    SWOT SWOT Analysis Findings StrengthsAffordable, Highly accessible, Internship Program, Experienced physicians ,Reputation, Trained staffs. Weaknesses Unhygienic environment, Old and inefficient building structure, Lack of technological advancements, Low doctor to patient ratio, Inefficient Patient monitoring. Opportunities Improved medical procedures, Research and innovation, therapeutic data monitoring, Digitalized records, Infrastructure facilities. Threats Budget constraints, Salary issue , Hospital acquired infection (HAI), Patient satisfaction , Rising cost.
  • 26.
  • 27.
    CONCLUSION Pabna General Hospitalis a public hospital ,funded by govt. It’s obvious that we won’t get quality treatment compared to high-end private hospital. There is no A grade pharmacist working in the hospital, low technology usage , inadequate physician and staff, lack of patient monitoring, inefficient patient medication history checking. However, it is a heaven for poor people, they can come here and get well with a low cost. There are a lots of area where improvements can be done. People involved are trying hard to improve the total service with best effort & team spirit. 27
  • 28.
    References 1. Vedantu. Hospital[Internet]. VEDANTU. Vedantu; 2022 [cited 2022Nov12]. Available from: https://www.vedantu.com/biology/hospital 2. Hospital pharmacist [Internet]. Hospital Pharmacist - an overview | ScienceDirect Topics. [cited 2022Nov12]. Available from: https://www.sciencedirect.com/topics/nursing-and-health- professions/hospital-pharmacist 3. Ketorolac: Medlineplus Drug Information [Internet]. MedlinePlus. U.S. National Library of Medicine; [cited 2022Nov12]. Available from: https://medlineplus.gov/druginfo/meds/a693001.html 28
  • 29.